普洛药业：2025年半年度归属于上市公司股东的净利润为563047273.19元

Core Insights - The company reported a revenue of 5,444,486,087.31 yuan for the first half of 2025, representing a year-on-year decline of 15.31% [2] - The net profit attributable to shareholders was 563,047,273.19 yuan, which is a decrease of 9.89% compared to the previous year [2] Financial Performance - Revenue for the first half of 2025: 5.44 billion yuan, down 15.31% year-on-year [2] - Net profit for the same period: 563 million yuan, down 9.89% year-on-year [2]